Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.25% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
COLL · Jun 30, 2026
COLLEGIUM PHARMACEUTICAL, INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-26-053851General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
35.68% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
6.32% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
56.67% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
55.18% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
1.85% · CORE · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
7.25% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20250/7 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.14%
- Current
- 0.25%
- Delta
- 0.11%
- Previous
- 29.51%
- Current
- 35.68%
- Delta
- 6.17%
- Previous
- 8.87%
- Current
- 6.32%
- Delta
- -2.55%
- Previous
- 22.09%
- Current
- 56.67%
- Delta
- 34.58%
- Previous
- 60.59%
- Current
- 55.18%
- Delta
- -5.41%
- Previous
- 15.97%
- Current
- 1.85%
- Delta
- -14.12%
- Previous
- 5.62%
- Current
- 7.25%
- Delta
- 1.62%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Transitioned To · COLL Fundamental State →Transitioned To · COLL CAPEX_INTENSITY_INCREASED →Transitioned To · COLL CASH_GENERATION_INCREASED →Transitioned To · COLL GROWTH_DECREASED →Transitioned To · COLL INVENTORY_PRESSURE_INCREASED →Transitioned To · COLL MARGIN_DECREASED →Transitioned To · COLL PROFITABILITY_DECREASED →Transitioned To · COLL SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.